No abstract available.
Toes*

No abstract available.
Adenocarcinoma ; Neoplasm Metastasis ; Scrotum

STUDY DESIGN: Literature review. OBJECTIVES: To present updated information on the conservative treatment of osteoporotic spinal fractures (OSFs). SUMMARY OF LITERATURE REVIEW: The treatments of osteoporotic spinal fractures are bed rest, pain medication, bracing, exercise and rehabilitation, and osteoporosis medication. However, there is disagreement about the outcomes of these treatments. MATERIALS AND METHODS: Review of the relevant literature. RESULTS: In the case of osteoporotic spinal fractures, analgesic administration, bracing, physical therapy, and exercise should be conducted. In order to prevent secondary fractures, bisphosphonates, selective estrogen receptor modulators, strontium ranelate, or parathyroid hormone, which has proven efficacy with respect to the prevention of secondary fractures, should be prescribed. CONCLUSIONS: We should actively prevent the occurrence of secondary fractures with fracture healing by implementing a proven effective treatment for osteoporotic spinal fractures.
Bed Rest ; Braces ; Diphosphonates ; Fracture Healing ; Osteoporosis ; Parathyroid Hormone ; Rehabilitation ; Selective Estrogen Receptor Modulators ; Spinal Fractures* ; Strontium

Osteoporotic vertebral fracture is a disease condition with high morbidity and mortality, whose prevalence rises with mean increase in the life span. Conventional treatments for an osteoporotic vertebral fracture include bed rest, pain medication and brace implementation, but if the patient's pain is severe, cement augmentation procedures, including vertebroplasty and kyphoplasty, are performed. Vertebroplasty and kyphoplasty are relatively easy procedures that have been reported to be effective in controlling acute pain. But, the risk of complication and additional adjacent segment fracture and their superiority over conventional treatment remain debatable. Therefore, the authors have summarized the procedures, complications, and clinical evidence of vertebroplasty and kyphoplasty in this review.
Acute Pain ; Bed Rest ; Braces ; Kyphoplasty* ; Mortality ; Prevalence ; Vertebroplasty*

No abstract available.
Contrast Media*

No abstract available.
Biopsy* ; Prostate*

PURPOSE: To investigate clinical availability of AL-Scan(TM) (Nidek, Gamagori, Japan) by comparing corneal refractive power with AL-Scan(TM), Autokeratometer(TM) (Topcon KR-1, Tokyo, Japan) and Pentacam(TM) (Oculus, Wetzlar, Germany) devices. METHODS: Seventy-one patients (142 eyes) who visited our hospital for refractive surgery were tested using AL-Scan(R), Autokeratometer and Pentacam(R) and corneal refractive power was compared among devices. RESULTS: When comparing measurements with AL-Scan(R), Autokeratometer and Pentacam(R), the mean corneal refractive power was 43.37 +/- 1.32 D (2.4 mm zone), 43.35 +/- 1.32 D (3.3 mm zone), 43.36 +/- 1.35 D, and 43.35 +/- 1.36 D respectively and showed no significant differences. Corneal refractive power had strongly positive linear correlation (p < 0.001) and Bland-Altman plots showed high degree of agreement among AL-Scan(R), Autokeratometer and Pentacam(R) devices. CONCLUSIONS: Because measuring ocular biometry with AL-Scan(R) including axial length, intraocular lens power calculation and topography simultaneously is possible, clinical use is convenient. Corneal refractive power was not different when compared with autokeratometer and Pentacam(R) devices, thus, AL-Scan(R) can be used in the clinical environment.
Biometry ; Humans ; Lenses, Intraocular ; Refractive Surgical Procedures

No abstract available.

STUDY DESIGN: A review of literature including definition, diagnosis and treatment of neuropathic pain. OBJECTIVES: To review and discuss the treatment guideline for neuropathic pain. SUMMARY OF LITERATURE REVIEW: Neuropathic pains are characterized by partial or complete somatosensory change caused by various disorders affecting central and peripheral nervous system, and are especially problematic because of their severity, chronicity and resistance to simple analgesics. MATERIALS AND METHODS: Review of literature. RESULTS: Tricyclic antidepressants and the anticonvulsants gabapentin and pregablin were recommended as first-line treatments for neuropathic pain. Opioid analgesics and tramadol were recommended as second-line treatments that can be considered for first-line use in selected clinical circumstances. Other medications such as dual reuptake inhibitors of both serotonin and norepinephrine would be used in severe cases. More invasive interventions (e.g., spinal cord stimulation) may sometimes be helpful. CONCLUSIONS: Treatment must be individualized for each patient and aggressive, combinatory pharmacotherapy and multidisciplinary approach are recommended for the treatment of neuropathic pain.
Amines ; Analgesics, Opioid ; Anticonvulsants ; Antidepressive Agents, Tricyclic ; Cyclohexanecarboxylic Acids ; gamma-Aminobutyric Acid ; Humans ; Neuralgia ; Norepinephrine ; Peripheral Nervous System ; Serotonin ; Spinal Cord ; Tramadol

PURPOSE: The purpose of the study is to determine the efficacy and safety of needle revision of failed filtering blebs using preoperative mitomycin C (MMC) application. METHODS: We reviewed the records of 28 patients (31 eyes) who had undergone needle revision with MMC for the treatment of failed filtering bleb. MMC (0.02 mg/ml, 0.1 ml) was injected subconjunctivally one day before needle revision. RESULTS: Postopertive mean follow-up period was 42 weeks. Twenty five eyes (80.6%) were classified as surgical success which was defined as IOP less than 21 mmHg with or without any antiglaucomatous therapy. Intraocular pressure decreased from 25.5+/-6.0 mmHg before surgery to 18.6+/-5.2 mmHg at the last follow-up (p< 0.05). No serious complication was found. CONCLUSION: Our result suggested that needle revision with the preoperative subconjunctival injetion of mitomycin-C may be an effective and safe method to revive failed filtration blebs.
Blister* ; Filtration ; Follow-Up Studies ; Humans ; Intraocular Pressure ; Mitomycin* ; Needles*